ASIC vs HRTG

ASIC's Piotroski F-Score of 4/9 indicates a borderline stable financial health, falling short of strong fundamentals. The absence of an Altman Z-Score raises concern about default risk, especially given the company's lack of disclosed debt and cash metrics. While the Graham Number ($21.31) and intrinsic value ($11.06) suggest undervaluation, the current price of $19.36 trades at a premium to intrinsic value, likely due to strong profitability and recent earnings surprises. The stock shows solid growth momentum in revenue (17.9% YoY) and consistent earnings beats (3/4 quarters), but earnings declined 9% YoY, creating a mixed signal. Analysts maintain a 'buy' recommendation with a $26.80 target, indicating optimism despite the valuation premium.

HRTG presents a stark contradiction between extreme valuation attractiveness and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the stock trades at a very low P/E of 4.73 and well below its Graham Number ($49.47), the combination of heavy insider selling and a low current ratio (0.83) suggests significant underlying risk. Explosive earnings growth is not currently supported by organic revenue growth (2.40%), indicating potential non-recurring gains or aggressive accounting. The technical trend is heavily bearish, offsetting the bullish analyst recommendations.